Might be timely to once again revisit some fine research work by Hottod about the the significance of Orphan Drug status in this thread, and the overall trend towards increasing licensing/royalty arrangements, in comparison to our current 280 million MC:
http://hotcopper.com.au/threads/why...ts-before-rett-results.2323975/#post-13729158
and particularly this link:
The Art of the Deal Licensing Trends in Orphan Drugs
The Case for Yes, page-40
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.25 |
Change
-0.100(0.81%) |
Mkt cap ! $1.565B | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.25 | $12.02 | $3.677M | 302.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1579 | $12.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.26 | 1199 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |